In 2024, administration of the four FDA-approved RSV vaccinations was low, ranging from 0.27% to 0.58%, according to a poster ...

RSV is especially dangerous for young babies. But now there are maternal vaccines and antibodies to help protect babies from RSV early in life. Infants and children are at more risk when they ...

Samples were analyzed for SARS-CoV-2-specific antibody titers, neutralizing antibodies and memory T cell responses. Results: An extended dose interval was associated with improved breadth of ...

The results demonstrated that the mRNA vaccine induced high levels of RSV F protein-specific IgG and serum neutralizing antibody titers compared to the control. For the T2A-preF mRNA vaccine, the ...

Join 6,000 other Cincinnatians and get News about the African Americans' Dreams and Hopes for our City! The measles vaccine, which first became available in the U.S. in 1963, contains a live but ...

The Moderna vaccine faces stiff competition from RSV vaccines Arexvy and Abrysvo, marketed by GSK and Pfizer, respectively. Moderna expects to launch 10 new products over the next three years and ...

A pooled analysis of data for AstraZeneca and Sanofi's respiratory syncytial virus (RSV) antibody nirsevimab ... hit this year however when frontrunner GlaxoSmithKline was forced to halt the ...

In April 2016, the company entered into a platform technology transfer and license agreement with GSK to research, develop and commercialize up to six bispecific antibodies generated using their ...

In April 2016, we entered into a platform technology transfer and license agreement with GSK to research, develop and commercialize up to six bispecific antibodies generated using our Azymetric™ ...